|
RCEL | Avita Medical, Inc. |
|
|
RCEL | Avita Medical, Inc. |
| Surgical & Medical Instruments & Apparatus |
| Book value per $ invested | $ 0.02 |
| Leverage | 97.83% |
| Market Cap | $ 271.7m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -56.9m |
| Margin | -80.28% |
AVITA Medical Inc. is a commercial stage regenerative tissue company in the United States, Australia, and the United Kingdom. The company is headquartered in Valencia, California.